Buyout (LBO, MBO, MBI) • Healthcare Services

Ampersand Capital Partners Acquires BakoDx

On November 1, 2011, growth capital firm Ampersand Capital Partners acquired healthcare services company BakoDx

Acquisition Context
  • This is Ampersand Capital Partners’ 2nd transaction in the Healthcare Services sector.
  • This is Ampersand Capital Partners’ 27th transaction in the United States.
  • This is Ampersand Capital Partners’ 1st transaction in Georgia.
Investment Fate
  • BakoDx was recapitalized in 2016.
  • BakoDx was sold to a publicly-traded strategic buyer in 2025.

Explore All 1105 Buyout (LBO, MBO, MBI) Healthcare Services Deals - Search the Database Free


M&A Deal Summary

Date November 1, 2011
Target BakoDx
Sector Healthcare Services
Buyer(s) Ampersand Capital Partners
Deal Type Buyout (LBO, MBO, MBI)

Target Company

BakoDx

Alpharetta, Georgia, United States
BakoDx provides specialty laboratory testing services that offer a comprehensive testing menu, including complete anatomic pathology services, proprietary molecular genetic testing, and peripheral neuropathy immuno-histochemical testing. Bako is based in Alpharetta, Georgia.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1988
PE ASSETS 3.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.


Deal Context for Buyer #
Overall 27 of 86
Sector: Healthcare Services 2 of 3
Type: Buyout (LBO, MBO, MBI) 11 of 23
State: Georgia 1 of 1
Country: United States 27 of 70
Year: 2011 6 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-10-18 Endeca Technologies

Cambridge, Massachusetts, United States

Endeca Technologies, Inc. is a provider of unstructured data management, web commerce and business intelligence solutions.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-05-07 Bioventus

Durham, North Carolina, United States

Bioventus provides clinical and cost-effective therapies and diagnostics to help patients regain active lifestyles. The company's innovative products include bone stimulation devices and osteoarthritis joint fluid therapies. Bioventus was incorporated in 2011 and is based in Durham, North Carolina.

Buy -